Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6494281 | Metabolic Engineering | 2016 | 8 Pages |
Abstract
3-Hydroxypropionate (3HP) is an important platform chemical, and four 3HP biosynthetic routes were reported, in which the malonyl-CoA pathway has some expected advantages but presented the lowest 3HP yield. Here, we demonstrated that this low yield was caused by a serious functional imbalance between MCR-C and MCR-N proteins, responsible for the two-step reduction of malonyl-CoA to 3HP. Then we minimized the enzyme activity imbalance by directed evolution of rate-limiting enzyme MCR-C and fine tuning of MCR-N expression level. Combined with culture conditions optimization, our engineering approaches increased the 3HP titer 270-fold, from 0.15Â g/L to 40.6Â g/L, representing the highest 3HP production via malonyl-CoA pathway so far. This study not only significantly improved the 3HP productivity of recombinant Escherichia coli strain, but also proved the importance of metabolic balance in a multistep biosynthetic pathway, which should be always considered in any metabolic engineering study.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Changshui Liu, Yamei Ding, Rubing Zhang, Huizhou Liu, Mo Xian, Guang Zhao,